Company overview
Basic information
Company name
Homo genome, UAB
Company code
302781230
Registered address
Vilnius, Pušų g. 12-4, LT-08120
Registration date
2012-05-14
Company age: 14 y. 4 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Rental and operating of own or leased real estate
Ownership form
Private without foreign capital
Homo genome, UAB
Company code: 302781230
Address: Vilnius, Pušų g. 12-4, LT-08120
Download a detailed company report
Make confident decisions with all the information about Homo genome, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Homo genome, UAB is an operational private limited liability company registered in 2012. The company is a private entity with Lithuanian ownership, and its governance structure is listed as CEO only. It operates as a micro-sized enterprise in the national private non-financial companies sector. The company is registered in Vilnius, at Pušu g. 12-4, Vilniaus m. sav., Vilniaus apskr. Its activity is classified under EVRK code M.68.20.00, covering rental and operating of own or leased real estate.
The company’s share capital is EUR 5.8K. In financial year 2025, revenue amounted to EUR 96.0K and net profit to EUR 24.7K, with a profit margin of 25.7%. Revenue decreased by 8.0% year on year compared with 2024, while revenue over two years increased by 2.7%. Net profit remained positive across the latest reporting years, and equity improved to EUR 123.9K in 2025. Total assets stood at EUR 304.7K, with liabilities of EUR 180.8K. The company had 1 average employee in 2025 and 1 average employee so far in 2026.
The company’s share capital is EUR 5.8K. In financial year 2025, revenue amounted to EUR 96.0K and net profit to EUR 24.7K, with a profit margin of 25.7%. Revenue decreased by 8.0% year on year compared with 2024, while revenue over two years increased by 2.7%. Net profit remained positive across the latest reporting years, and equity improved to EUR 123.9K in 2025. Total assets stood at EUR 304.7K, with liabilities of EUR 180.8K. The company had 1 average employee in 2025 and 1 average employee so far in 2026.